Natural Capsules Limited has informed the Exchange about General Updates

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-7.1%1-day move

₹169.99

prior close

₹160.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+3.7+2.5+2.5+1.5-7.1-7.8-7.1-8.6-7.3-8.2-5.3-10.4——

Up moveDown movePending

AI summary

Natural Capsules Limited's material subsidiary, Natural Biogenex Private Limited, has approved a rights issue of 11,11,200 equity shares of ₹10 each at par value. The issue aggregates to ₹1,11,12,000 (approximately ₹1.11 crore). The rights issue was approved at the subsidiary's board meeting held on May 27, 2026. The filing is made under SEBI (LODR) Regulation 30(9) disclosure requirements. Natural Capsules holds the scrip code 524654 and trades under the symbol NATCAPSUQ.

Likely market impact

Since this is a rights issue by the subsidiary rather than the parent company, the direct dilution impact on Natural Capsules shareholders is limited. The ₹1.11 crore raised by the subsidiary may support its growth, but the filing does not specify how the proceeds will be used.